Advanced search
Publication Cover
Acta Cardiologica Volume 74, 2019 - Issue 2
Submit an article Journal homepage
269
Views
23
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Meta-analysis of randomized trials on percutaneous patent foramen ovale closure for prevention of migraine

Ayman ElbadawiDepartment of Internal Medicine, Rochester General Hospital, Rochester, NY, USA; ;Department of Cardiovascular Medicine, Ain Shams University, Cairo, Egypt; Correspondence[email protected]
,
Kirolos BarssoumDepartment of Internal Medicine, Rochester General Hospital, Rochester, NY, USA;
,
Ahmed S. AbuzaidSidney Kimmel Medical College at Thomas Jefferson University/Christiana Care Health System, Newark, DE, USA;
,
Ahmed RezqDepartment of Cardiovascular Medicine, Ain Shams University, Cairo, Egypt;
,
Nishit BiniwaleDepartment of Internal Medicine, Rochester General Hospital, Rochester, NY, USA;
,
Erfan AlotakiDepartment of Internal Medicine, Rochester General Hospital, Rochester, NY, USA;
,
Ahmed H. MohamedDepartment of Internal Medicine, Rochester General Hospital, Rochester, NY, USA;
,
Sowjanya VuyyalaDepartment of Internal Medicine, Rochester General Hospital, Rochester, NY, USA;
,
Gbolahan O OgunbayoDivision of cardiovascular Medicine, University of Kentucky, Lexington, KY, USA;
&
Marwan SaadDepartment of Cardiovascular Medicine, Ain Shams University, Cairo, Egypt; ;Department of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
 show all
Pages 124-129 | Received 15 Jan 2018, Accepted 01 May 2018, Published online: 18 Jun 2018

References

  • Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28:531–540.
  • Patti G, Pelliccia F, Gaudio C, et al. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Am J Cardiol. 2015;115:837–843.
  • Mojadidi MK, Elgendy AY, Elgendy IY, et al. Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials. JACC: Cardiovasc Interv. 2017;10:2228–2230.
  • Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397–1404.
  • Tobis JM, Charles A, Silberstein SD, et al. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine. The PREMIUM Trial. J Am Coll Cardiol. 2017;70:2766–2774.
  • Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37:2029–2036.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
  • Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323:42
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.
  • Steiner TJ, Birbeck GL, Jensen RH, et al. Headache disorders are third cause of disability worldwide. J Headache Pain. 2015;16:1–3.
  • Choi DY, Shin DH, Cho KH, et al. Migraine with aura: a predictor of patent foramen ovale in children and adolescents. Cephalalgia. 2013;33:463–468.
  • Shi Y-J, Lv J, Han X-T, et al. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17:203.
  • Butera G, Agostoni E, Biondi-Zoccai G, et al. Migraine, stroke and patent foramen ovale: a dangerous trio? J Cardiovasc Med (Hagerstown). 2008;9:233–238.
  • Kanwar SM, Noheria A, DeSimone CV, et al. Coincidental impact of transcatheter patent foramen ovale closure on migraine with and without Aura – a comprehensive meta-analysis. Clin Trials Regul Sci Cardiol. 2016;15:7–13.
  • Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033–1042.
  • Tfelt-Hansen P, Block G, Dahlöf C, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765–786.
  • Silberstein SD. Preventive migraine treatment. Neurol Clin. 2009;27:429–443.
  • Estemalik E, Tepper S. Preventive treatment in migraine and the new US guidelines. Neuropsychiatr Dis Treat. 2013;9:709
  • Zdradzinski MJ, Elkin RL, Lee JM, et al. Contributors to and impact of residual shunting after device closure of atrial septal defects. Am Heart J. 2016;177:112–119.
  • Luermans JG, Post MC, Plokker H, et al. Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke. Neth Heart J. 2008;16:332–336.
  • Rigatelli G, Dell’Avvocata F, Cardaioli P, et al. Migraine-patent foramen ovale connection: role of prominent eustachian valve and large Chiari network in migrainous patients. Am J Med Sci. 2008;336:458–461.
  • Rigatelli G, Cardaioli P, Dell'Avvocata F, et al. May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression? Cardiovasc Revascular Med. 2011;12:217–219.
  • Zeller J, Frahm K, Baron R, et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry. 2004;75:984–987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.